Updated Checklist for Reporting Diagnostic Accuracy Studies

Share this content:
Updated Checklist for Reporting Diagnostic Accuracy Studies
Updated Checklist for Reporting Diagnostic Accuracy Studies

FRIDAY, Nov. 6, 2015 (HealthDay News) -- An updated list of 30 essential items should be included in every report of a diagnostic accuracy study, according to the Standards for Reporting Diagnostic Accuracy Studies (STARD) 2015. These new guidelines have been published in several journals, including Radiology, Clinical Chemistry, and The BMJ.

Patrick M. Bossuyt, Ph.D., from the University of Amsterdam, and colleagues reviewed the literature and presented an updated list of 30 essential items that should be included in every report of a diagnostic accuracy study. The update includes recent evidence about sources of bias and variability in diagnostic accuracy.

The authors note that new items in STARD 2015 include a structured abstract; intended use and clinical role of the test; study hypotheses; sample size; structured discussion; registration; protocol; and sources of funding. The updated STARD was designed to apply to all types of medical tests. Extensions may be necessary for specific types of tests, specific applications, or specific forms of analysis.

"This is really the question of how do you know the test to diagnose disease really does diagnose disease," a coauthor said in a statement. "It sounds like such a simple question to ask, but like most simple questions, it turns out it's not so easy."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »